Extended antiplatelet therapy with clopidogrel alone versus clopidogrel plus aspirin after completion of 9-to 12-month dual antiplatelet therapy for acute coronary …

Y Li, Q Jing, B Wang, X Wang, J Li, S Qiao, S Chen… - American Heart …, 2020 - Elsevier
Background Dual antiplatelet therapy with aspirin and a P2Y12 inhibitor is the cornerstone
for prevention ischemic events in patients with acute coronary syndromes (ACS) and …
被引用次数：14 相关文章

Extended antiplatelet therapy with clopidogrel alone versus clopidogrel plus aspirin after completion of 9-to 12-month dual antiplatelet therapy for acute coronary …

Y Li, Q Jing, B Wang, X Wang, J Li… - American heart …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Dual antiplatelet therapy with aspirin and a P2Y12 inhibitor is the cornerstone
for prevention ischemic events in patients with acute coronary syndromes (ACS) and …

Extended antiplatelet therapy with clopidogrel alone versus clopidogrel plus aspirin after completion of 9-to 12-month dual antiplatelet therapy for acute coronary …

Y Li, Q Jing, B Wang, X Wang, J Li, S Qiao… - American Heart …, 2020 - europepmc.org
Background Dual antiplatelet therapy with aspirin and a P2Y12 inhibitor is the cornerstone
for prevention ischemic events in patients with acute coronary syndromes (ACS) and …
[HTML] nih.gov

[HTML][HTML] Extended antiplatelet therapy with clopidogrel alone versus clopidogrel plus aspirin after completion of 9-to 12-month dual antiplatelet therapy for acute …

Y Li, Q Jing, B Wang, X Wang, J Li, S Qiao… - American Heart …, 2020 - ncbi.nlm.nih.gov
Background Dual antiplatelet therapy with aspirin and a P2Y12 inhibitor is the cornerstone
for prevention ischemic events in patients with acute coronary syndromes (ACS) and …